Politics - STAT

Politics

Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals

By Nicholas Florko

Politics

9 ways Covid-19 may forever upend the U.S. health care industry

By Lev Facher

Politics

In combative remarks, Azar tells WHO that its Covid-19 response ‘cost many lives’

By Lev Facher

Politics

Trump administration outlines audacious plan to deliver ‘hundreds of millions’ of Covid-19 vaccine doses by end of 2020

By Lev Facher

Politics

Rick Bright is facing attacks from Republicans across Washington, but his opponents can’t seem to land a punch

By Nicholas Florko

Politics

Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response

By Nicholas Florko

Exclusive

Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?

By Nicholas Florko and Matthew Herper

Politics

Trump administration proposes a dramatic payment boost for CAR-T treatments under Medicare

By Nicholas Florko

Politics

14 questions for Fauci, Redfield, and other Trump officials testifying today on the coronavirus

By STAT staff

Health

Doctors lambaste federal process for distributing Covid-19 drug remdesivir

By Eric Boodman and Casey Ross

Politics

Vaccine expert says he was punished for raising concerns about Trump’s coronavirus response, nepotism

By Nicholas Florko

Politics

NIH announces $1.5 billion, ‘Shark Tank’-like initiative to accelerate Covid-19 testing

By Lev Facher

Politics

A bipartisan group of former health officials seeks to sell a $46.5 billion coronavirus plan to the White House

By Lev Facher

Politics

How a Los Angeles doctor got swept up in the swirl of the Trump White House as it confronts the pandemic

By Rebecca Robbins and Nicholas Florko

Politics

Trump hopes for 2 million tests per week by end of May — the low end of experts’ estimates of what’s needed to reopen

By Lev Facher

Politics

Why was an obscure federal bureaucrat involved in Trump’s emergency hydroxychloroquine authorization?

By Nicholas Florko

Politics

An ousted vaccine agency director offers an explosive, direct allegation: Trump is politicizing science

By Nicholas Florko

Exclusive

Director of U.S. agency key to vaccine development leaves role suddenly amid coronavirus pandemic

By Nicholas Florko

Politics

NIH Director Francis Collins on Tony Fauci, the WHO, and running a $39 billion research agency from home

By Lev Facher

Politics

General Motors, 3M, and pharma companies beef up lobbying firepower amid coronavirus pandemic

By Lev Facher

Politics

After a hard-won political fight, this state expanded access to insulin. Can others follow its lead?

By Nicholas Florko

Politics

NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines

By Lev Facher

Politics

Trump outlines ‘phases’ for reopening states once coronavirus cases begin to decline

By Lev Facher

Politics

Trump announces a formal freeze on WHO funding, pending an investigation

By Nicholas Florko

Politics

State legislatures are lapping the federal government on drug pricing — even amid the coronavirus

By Nicholas Florko

Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19 pandemic

Trump tries to convince voters he’s lowered drug prices, based only on a modest tweak to Medicare

Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.

FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on Covid-19 vaccine project

Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals

9 ways Covid-19 may forever upend the U.S. health care industry

In combative remarks, Azar tells WHO that its Covid-19 response ‘cost many lives’

Trump administration outlines audacious plan to deliver ‘hundreds of millions’ of Covid-19 vaccine doses by end of 2020

Rick Bright is facing attacks from Republicans across Washington, but his opponents can’t seem to land a punch

Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response

Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?

Trump administration proposes a dramatic payment boost for CAR-T treatments under Medicare

14 questions for Fauci, Redfield, and other Trump officials testifying today on the coronavirus

Doctors lambaste federal process for distributing Covid-19 drug remdesivir

Vaccine expert says he was punished for raising concerns about Trump’s coronavirus response, nepotism

NIH announces $1.5 billion, ‘Shark Tank’-like initiative to accelerate Covid-19 testing

A bipartisan group of former health officials seeks to sell a $46.5 billion coronavirus plan to the White House

How a Los Angeles doctor got swept up in the swirl of the Trump White House as it confronts the pandemic

Trump hopes for 2 million tests per week by end of May — the low end of experts’ estimates of what’s needed to reopen

Why was an obscure federal bureaucrat involved in Trump’s emergency hydroxychloroquine authorization?

An ousted vaccine agency director offers an explosive, direct allegation: Trump is politicizing science

Director of U.S. agency key to vaccine development leaves role suddenly amid coronavirus pandemic

NIH Director Francis Collins on Tony Fauci, the WHO, and running a $39 billion research agency from home

General Motors, 3M, and pharma companies beef up lobbying firepower amid coronavirus pandemic

After a hard-won political fight, this state expanded access to insulin. Can others follow its lead?

NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines

Trump outlines ‘phases’ for reopening states once coronavirus cases begin to decline

Trump announces a formal freeze on WHO funding, pending an investigation

State legislatures are lapping the federal government on drug pricing — even amid the coronavirus